Literature DB >> 11272201

Roles of ATP-sensitive K+ channels in cell survival and differentiation in the endocrine pancreas.

T Miki1, T Iwanaga, K Nagashima, Y Ihara, S Seino.   

Abstract

To determine the roles of the ATP-sensitive K+ (K(ATP)) channels in endocrine pancreas more directly, two types of genetically engineered Kir6.2 mice were developed: mice expressing a dominant-negative form of Kir6.2 specifically in beta-cells (Kir6.2G132S Tg mice) and mice lacking Kir6.2 (Kir6.2-/- or Kir6.2 null mice). The Kir6.2G132S Tg mice show severe impairment of K(ATP) channel function only in the beta-cells, whereas Kir6.2 null mice are completely defective in K(ATP) channel function in all of the cells in which Kir6.2 is a constituent of the K(ATP) channels, because of the disruption of Kir6.2. Both types of mice show abnormal architecture of the pancreatic islets. The number of beta-cells in Kir6.2G132S Tg mice decreases markedly with age, whereas that in Kir6.2-/- mice decreases slightly. alpha-Cells, which are normally present only in the periphery of pancreatic islets, also appear in the center of the islets in both Kir6.2G132S Tg and Kir6.2-/- mice. Interestingly, the number of peptide YY (PYY) and glucagon-positive cells is markedly increased in Kir6.2 null mice, whereas the number of PP cells and delta-cells is not altered. Apoptotic cells are detected by the TdT-mediated dUTP nick-end labeling (TUNEL) method at a high frequency in both Kir6.2G372S Tg and Kir6.2-/- mice compared with the respective controls. Thus, studies of Kir6.2G372S Tg and Kir6.2-/- mice indicate that K(ATP) channels play an important role in cell survival and differentiation in the endocrine pancreas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272201     DOI: 10.2337/diabetes.50.2007.s48

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

Review 1.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

Review 2.  ATP-sensitive potassium channelopathies: focus on insulin secretion.

Authors:  Frances M Ashcroft
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 3.  Bioelectric mechanisms in regeneration: Unique aspects and future perspectives.

Authors:  Michael Levin
Journal:  Semin Cell Dev Biol       Date:  2009-05-03       Impact factor: 7.727

Review 4.  Endogenous voltage gradients as mediators of cell-cell communication: strategies for investigating bioelectrical signals during pattern formation.

Authors:  Dany S Adams; Michael Levin
Journal:  Cell Tissue Res       Date:  2012-02-17       Impact factor: 5.249

Review 5.  Planarian regeneration as a model of anatomical homeostasis: Recent progress in biophysical and computational approaches.

Authors:  Michael Levin; Alexis M Pietak; Johanna Bischof
Journal:  Semin Cell Dev Biol       Date:  2018-05-01       Impact factor: 7.727

6.  Molecular bioelectricity: how endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo.

Authors:  Michael Levin
Journal:  Mol Biol Cell       Date:  2014-12-01       Impact factor: 4.138

7.  Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation.

Authors:  Akiko Saito-Hakoda; Tohru Yorifuji; Junko Kanno; Shigeo Kure; Ikuma Fujiwara
Journal:  Clin Pediatr Endocrinol       Date:  2012-07-25

8.  Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.

Authors:  Christophe A Girard; F Thomas Wunderlich; Kenju Shimomura; Stephan Collins; Stephan Kaizik; Peter Proks; Fernando Abdulkader; Anne Clark; Vicky Ball; Lejla Zubcevic; Liz Bentley; Rebecca Clark; Chris Church; Alison Hugill; Juris Galvanovskis; Roger Cox; Patrik Rorsman; Jens C Brüning; Frances M Ashcroft
Journal:  J Clin Invest       Date:  2008-12-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.